Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine for Vasopressor Liberation in ICU (LIBERATE Pilot)
NCT04489589Phase 4Completed
- Sponsor
- University of Alberta
- Start
- Mar 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of midodrine in hypotension, Shock, sponsored by University of Alberta. Started Mar 2021; status: completed.
02
Drugs
midodrine
03
Conditions
hypotensionShock
Beyond the preview
Go deeper on NCT04489589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04489589.